Clinical Trials
3 trialsNCT02101788 2025-11-13
Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT04159155 2025-08-12
CAN-STAMP
University Health Network, Toronto
Phase 2/3 Terminated
NCT04055038 2019-08-13
EPITOC
Blokhin's Russian Cancer Research Center
Phase 2/3 Unknown